Loading insider details...
Latest Form 4 (Nov 3, 2026): Grant/Award of 613 MRK shares, $91.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 3, 2026 | Merck & Co., Inc. (MRK) | Grant/Award | 613 | $91.7K |
| Jul 28, 2026 | CENTENE CORP (CNC) | Grant/Award | 2,771 | n/a |
| Mar 25, 2025 | MYRIAD GENETICS INC (MYGN) | Tax Withholding | 19,859 | $198.8K |
| Mar 17, 2025 | MYRIAD GENETICS INC (MYGN) | Tax Withholding | 37,564 | $378.3K |
| Mar 5, 2025 | MYRIAD GENETICS INC (MYGN) | Grant/Award | 114,828 | n/a |
| Oct 11, 2024 | MYRIAD GENETICS INC (MYGN) | Sale | 15,000 | $343.9K |
| Sep 12, 2024 | MYRIAD GENETICS INC (MYGN) | Sale | 15,000 | $400.8K |
| Aug 14, 2024 | MYRIAD GENETICS INC (MYGN) | Tax Withholding | 22,808 | $642.7K |
| May 15, 2024 | MYRIAD GENETICS INC (MYGN) | Sale | 57,844 | $1.45M |
| Mar 25, 2024 | MYRIAD GENETICS INC (MYGN) | Tax Withholding | 20,202 | $449.3K |